Murray

Brean, Murray, Carret & Co. analyst Ananda Baruah reiterated a Buy rating for shares of Xyratex Ltd. (NASDAQ: XRTX), with a price target of $24 per share. Baruah recommended buying aggressively during unwarranted sell-offs of Xyratex Ltd. stock. The analyst noted that shares of Xyratex Ltd....

Brean, Murray, Carret & Co. analyst Ingrid Yin maintained her Buy rating for shares of China Biologic Products, Inc. (Nasdaq: CBPO) and raised the price target to $20 per share, from the previous price target of $19. The analysts said that China Biologic Products, Inc. had announced that the...